Back to Ophthalmology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Emerging Ophthalmology

Overview

Spherix’s coverage of emerging ophthalmology indications focuses on evolving markets where a paradigm shift is expected in the coming years.

Services Available

Prepping for the pipeline

  • Dry Age-Related Macular Degeneration / Geographic Atrophy (US)

Service Info

Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents and select KOLs.

Sample Size and Frequency

Annual report (n=100-200 physicians)

Qualitative interviews (n=6-8 physicians, n=2-3 KOLs)

Benchmarking new brand performance

  • Byooviz (Samsung Bioepis and Biogen) Ranibizumab Biosimilar (US)

  • FYB201 (Coherus BioSciences) Ranibizumab Biosimilar (US)*

*Pending approvals and launch

Service Info

Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of physicians “in the trenches” recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents.

Sample Size and Frequency

Monthly KPI benchmarking (n=75 physicians)

Quarterly report (n=75 physicians)

Quarterly qualitative interviews (n=8 physicians)

Gauging impact of disruptive events

  • Ophthalmology Biosimilars Today and Tomorrow (US)

Service Info

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Learn more about our services

HOW CAN WE PARTNER TOGETHER?

Get more information on Emerging (Dry AMD, Geographic Atrophy...) Coverage